Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MS von HUIJBREGTS, S. C. J, KALKERS, N. F, DE SONNEVILLE, L. M. J, DE GROOT, V, REULING, I. E. W, POLMAN, C. H

Volltext

Safety, tolerability, and efficacy of orally administered cannabinoids in MS von KILLESTEIN, J, HOOGERVORST, E. L. J, REIF, M, KALKERS, N. F, VAN LOENEN, A. C, STAATS, P. G. M, GORTER, R. W, UITDEHAAG, B. M. J, POLMAN, C. H

Volltext

The effect of the neuroprotective agent riluzole on MRI parameters in primary progressive multiple sclerosis: a pilot study von Kalkers, N F, Barkhof, F, Bergers, E, van Schijndel, R, Polman, C H

Volltext

Anxiety and depression influence the relation between disability status and quality of life in multiple sclerosis von JANSSENS, A. C. J. W, VAN DOORN, P. A, DE BOER, J. B, KALKERS, N. F, VAN DER MECHE, F. G. A, PASSCHIER, J, HINTZEN, R. Q

Volltext

A longitudinal study of cognition in primary progressive multiple sclerosis von Camp, S. J., Stevenson, V. L., Thompson, A. J., Ingle, G. T., Miller, D. H., Borras, C., Brochet, B., Dousset, V., Falautano, M., Filippi, M., Kalkers, N. F., Montalban, X., Polman, C. H., Langdon, D. W.

Volltext

Ocrelizumab after natalizumab in JC-virus positive relapsing remitting multiple sclerosis patients von van Lierop, ZYGJ, Toorop, AA, Coerver, EME, Willemse, EAJ, Strijbis, EMM, Kalkers, NF, Moraal, B, Barkhof, F, Teunissen, CE, Killestein, J, van Kempen, ZLE

Volltext

The Brief Repeatable Battery of Neuropsychological Tests: normative values allow application in multiple sclerosis clinical practice von Boringa, J.B., Lazeron, R.H.C., Reuling, I.E.W., Adèr, H.J., Pfennings, L.E.M.A., Lindeboom, J., de Sonneville, L.M.J., Kalkers, N.F., Polman, C.H.

Volltext

Optimizing the association between disability and biological markers in MS von KALKERS, N. F, BERGERS, E, CASTELIJNS, J. A, VAN WALDERVEEN, M. A. A, BOT, J. C. J, ADER, H. J, POLMAN, C. H, BARKHOF, F

Volltext

Long-term clinical outcome of primary progressive MS : Predictive value of clinical and MRI data von SASTRE-GARRIGA, J, INGLE, G. T, BARKHOF, F, BROCHET, B, DOUSSET, V, FILIPPI, M, MONTALBAN, X, KALKERS, N. F, POLMAN, C. H, ROVIRA, A, MILLER, D. H, THOMPSON, A. J, ROVARIS, M, TELLEZ, N, JASPERSE, B, ALTMANN, D. R, BENEDETTI, B, STEVENSON, V. L, CERCIGNANI, M, LEARY, S. M

Volltext

Influence of personalized extended interval dosing on the natalizumab wearing-off effect - a sub-study of the NEXT-MS trial von Toorop, A.A., Wessels, M.H.J., Gelissen, L.M.Y., Hoitsma, E., Zeinstra, E.M.P.E., van Rooij, L.C., van Munster, C.E.P., Vennegoor, A., Mostert, J.P., Wokke, B.H.A., Kalkers, N.F., Hoogervorst, E.L.J., van Eijk, J.J.J., Roosendaal, C.M., Kragt, J.J., Eurelings, M., van Genugten, J., Nielsen, J., Sinnige, L.G.F., Kloosterziel, M.E., Arnoldus, E.P.J., van Dijk, G.W., Bouvy, W.H., Strijbis, E.M.M., van Oosten, B.W., de Jong, B.A., Lissenberg-Witte, B.I., Rispens, T., Uitdehaag, B.M.J., Killestein, J., van Kempen, Z.L.E.

Volltext

Motor evoked potential: A reliable and objective measure to document the functional consequences of multiple sclerosis? Relation to disability and MRI von Kalkers, N.F, Strijers, R.L.M, Jasperse, M.M.S, Neacsu, V, Geurts, J.J.G, Barkhof, F, Polman, C.H, Stam, C.J

Volltext

Brain atrophy in multiple sclerosis: impact of lesions and of damage of whole brain tissue von Kalkers, N F, Vrenken, H, Uitdehaag, B MJ, Polman, C H, Barkhof, F

Volltext

MS Functional Composite : Relation to disease phenotype and disability strata von KALKERS, N. F, DE GROOT, V, LAZERON, R. H. C, KILLESTEIN, J, ADER, H. J, BARKHOF, F, LANKHORST, G. J, POLMAN, C. H

Volltext

Comparisons of patient self-report, neurologic examination, and functional impairment in MS von HOOGERVORST, E. L. J, VAN WINSEN, L. M. L, EIKELENBOOM, M. J, KALKERS, N. F, UITDEHAAG, B. M. J, POLMAN, C. H

Volltext

The patient's perception of a (reliable) change in the Multiple Sclerosis Functional Composite von HOOGERVORST, E. L. J, KALKERS, N. F, CUTTERS, G. R, UITDEHAAG, B. M. J, POLMAN, C. H

Volltext

Concurrent validity of the MS Functional Composite using MRI as a biological disease marker von KALKERS, N. F, BERGERS, L, DE GROOT, V, LAZERON, R. H. C, VAN WALDERVEEN, M. A. A, UITDEHAAG, B. M. J, POLMAN, C. H, BARKHOF, F

Volltext

Cross-sectional and longitudinal correlations between the Arm Function in Multiple Sclerosis Questionnaire (AMSQ) and other outcome measures in multiple sclerosis von Molenaar, P.C.G., Strijbis, E.M.M., van Munster, C.E.P., Uitdehaag, B.M.J., Kalkers, N.F.

Volltext

Magnetization transfer histogram parameters reflect all dimensions of MS pathology, including atrophy von Kalkers, N.F., Hintzen, R.Q., van Waesberghe, J.H.T.M., Lazeron, R.H.C., van Schijndel, R.A., Adèr, H.J., Polman, C.H., Barkhof, F.

Volltext

The use of multi-domain patient reported outcome measures for detecting clinical disease progression in multiple sclerosis von van ‘t Hullenaar, C.A.A., Coerver, E., Kalkers, N.F., van Kempen, Z., Koch, M., Uitdehaag, B.M.J., Killestein, J., Strijbis, E.M.M.

Volltext

Responder rates to fampridine differ between clinical subgroups of MS patients and patient reported outcome influences treatment decision making von van Munster, C.E.P., Kaya, L., Lam, K.H., Kalkers, N.F., Killestein, J., Uitdehaag, B.M.J.

Volltext